{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:13:03Z","timestamp":1790673183022,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jaip.2024.08.034","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T07:27:32Z","timestamp":1724484452000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mast Cell Disorders and Hymenoptera Venom-Triggered Anaphylaxis: Evaluation and Management"],"prefix":"10.1016","volume":"13","author":[{"given":"Nathan A.","family":"Boggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Tanasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Zanotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gonzalez-de-Olano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.08.034_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaci.2005.01.005","article-title":"Insect sting allergy and venom immunotherapy: a model and a mystery","volume":"115","author":"Golden","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib2","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1111\/j.1365-2222.2009.03324.x","article-title":"The natural history and epidemiology of insect venom allergy: clinical implications","volume":"39","author":"Bil\u00f2","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2174\/1381612828666220817091039","article-title":"Hymenoptera venom allergy and anaphylaxis","volume":"29","author":"Bil\u00f2","year":"2023","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaip.2024.08.034_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0091-6749(97)70270-7","article-title":"Natural history of Hymenoptera venom sensitivity in adults","volume":"100","author":"Golden","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib5","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/all.15769","article-title":"Allergy to stings and bites from rare or locally important arthropods: worldwide distribution, available diagnostics and treatment","volume":"78","author":"Sturm","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/all.13945","article-title":"Risk factors and indicators of severe systemic insect sting reactions","volume":"75","author":"Stoevesandt","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib7","first-page":"288","article-title":"Mastocytosis and allergic diseases","volume":"24","author":"Bonadonna","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.18176\/jiaci.0233","article-title":"Prevalence of clonal mast cell disorders in patients presenting with hymenoptera venom anaphylaxis might be higher than expected","volume":"28","author":"V\u00e1zquez-Revuelta","year":"2018","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0091-6749(83)90630-9","article-title":"Anaphylaxis after Hymenoptera stings in three patients with urticaria pigmentosa","volume":"72","author":"M\u00fcller","year":"1983","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2796.1993.tb00984.x","article-title":"Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis","volume":"233","author":"Kors","year":"1993","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jaip.2024.08.034_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(00)03647-3","article-title":"Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings","volume":"357","author":"Ludolph-Hauser","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.08.034_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/bmj.2.455.323","article-title":"Reports of medical and surgical practice in the hospitals of Great Britain","volume":"2","author":"Nettleship","year":"1869","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2024.08.034_bib14","first-page":"426","article-title":"Urticaria pigmentosa; a report of a case with autopsy","volume":"48","author":"Ellis","year":"1949","journal-title":"Arch Pathol (Chic)"},{"key":"10.1016\/j.jaip.2024.08.034_bib15","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2024.08.034_bib16","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.08.034_bib17","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2024.08.034_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.08.034_bib19","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.jaip.2022.03.007","article-title":"Personalized management strategies in mast cell disorders: ECNM-AIM user\u2019s guide for daily clinical practice","volume":"10","author":"Valent","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"Alvarez-Twose","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib21","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1111\/all.16132","article-title":"Prevalence of hypersensitivity reactions in various forms of mastocytosis: a pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry","volume":"79","author":"Niedoszytko","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib22","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.iac.2023.04.011","article-title":"World health organization classification and diagnosis of mastocytosis: update 2023 and future perspectives","volume":"43","author":"Valent","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.08.034_bib23","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jaip.2022.05.007","article-title":"Global classification of mast cell activation disorders: An ICD-10-CM-adjusted proposal of the ECNM-AIM Consortium","volume":"10","author":"Valent","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2024.08.034_bib25","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.3390\/cancers13246380","article-title":"A\u00a0multidisciplinary diagnostic approach reveals a higher prevalence of indolent systemic mastocytosis: 15-years\u2019 experience of the GISM Network","volume":"13","author":"Zanotti","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jaip.2024.08.034_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/1651-226X.2024.31406","article-title":"Epidemiology of mastocytosis: a population-based study (Sweden)","volume":"63","author":"Bergstr\u00f6m","year":"2024","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jaip.2024.08.034_bib27","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1182\/blood-2023-188451","article-title":"Incidence and prevalence of mastocytosis in adults: A Danish nationwide register study","volume":"142","author":"Joergensen","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.08.034_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience","volume":"44","author":"G\u00fclen","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11882-014-0450-8","article-title":"Anaphylaxis as a clinical manifestation of clonal mast cell disorders","volume":"14","author":"Matito","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2024.08.034_bib31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2021.02.043","article-title":"Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone","volume":"148","author":"\u0160elb","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased \u03b1-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib34","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/all.16084","article-title":"High burden of clonal mast cell disorders and hereditary \u03b1-tryptasemia in patients who need Hymenoptera venom immunotherapy","volume":"79","author":"Koro\u0161ec","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.iac.2018.04.006","article-title":"Patient perceptions in mast cell disorders","volume":"38","author":"Jennings","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.08.034_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2014.11.035","article-title":"Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels","volume":"136","author":"Zanotti","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib37","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.jaip.2019.04.003","article-title":"Maculopapular cutaneous mastocytosis in a diverse population","volume":"7","author":"Kirshenbaum","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0091-6749(97)81058-5","article-title":"Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis","volume":"99","author":"Oude Elberink","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216368","article-title":"Fatal Hymenoptera venom-triggered anaphylaxis in patients with unrecognized clonal mast cell disorder-is mastocytosis to blame?","volume":"24","author":"Rijavec","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2024.08.034_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000113520","article-title":"Fatal anaphylactic sting reaction in a patient with mastocytosis","volume":"146","author":"Wagner","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib41","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood.2023023347","article-title":"Standardized indolent systemic mastocytosis evaluations across a health care system: implications for screening accuracy","volume":"144","author":"McMurray","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.08.034_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/modpathol.2013.117","article-title":"Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis","volume":"27","author":"Berezowska","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaip.2024.08.034_bib44","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib45","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jaci.2015.05.034","article-title":"Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis","volume":"136","author":"Wiechers","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib46","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/ced.15262","article-title":"Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children","volume":"47","author":"Hermans","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaip.2024.08.034_bib47","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib48","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1182\/bloodadvances.2022007936","article-title":"Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms","volume":"7","author":"Chovanec","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2024.08.034_bib49","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.jaip.2021.12.031","article-title":"Elevated basal serum tryptase: disease distribution and variability in a regional health system","volume":"10","author":"Waters","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaci.2021.06.017","article-title":"Hereditary alpha tryptasemia is not associated with specific clinical phenotypes","volume":"149","author":"Chollet","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11882-009-0010-9","article-title":"The problem of anaphylaxis and mastocytosis","volume":"9","author":"M\u00fcller","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2024.08.034_bib52","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/all.15911","article-title":"Clinical impact of the TPSAB1 genotype in mast cell diseases: a REMA study in a cohort of 959 individuals","volume":"79","author":"Gonz\u00e1lez-de-Olano","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib53","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonz\u00e1lez de Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.18176\/jiaci.0310","article-title":"Hymenoptera venom allergy: management of children and adults in clinical practice","volume":"29","author":"Bil\u00f2","year":"2019","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib55","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jaip.2017.03.019","article-title":"Fatal anaphylaxis to yellow jacket stings in mastocytosis: options for identification and treatment of at-risk patients","volume":"5","author":"Vos","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib56","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/all.13262","article-title":"EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy","volume":"73","author":"Sturm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib57","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.b.20577","article-title":"Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis","volume":"80","author":"Gonz\u00e1lez-de-Olano","year":"2011","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jaip.2024.08.034_bib58","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1398-9995.2012.02849.x","article-title":"The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera sting","volume":"67","author":"Bonadonna","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib59","doi-asserted-by":"crossref","first-page":"65","DOI":"10.18176\/jiaci.0442","article-title":"The method for selecting basophils might be determinant in the basophil activation test in patients with mastocytosis","volume":"30","author":"Urra","year":"2020","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib60","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.jaip.2022.03.001","article-title":"Standards of genetic testing in the diagnosis and prognostication of systemic mastocytosis in 2022: recommendations of the EU-US Cooperative Group","volume":"10","author":"Hoermann","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib61","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/all.15584","article-title":"KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes","volume":"78","author":"Navarro-Navarro","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib62","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2015-07-655100","article-title":"KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression","volume":"127","author":"Garcia-Montero","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.08.034_bib63","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1200\/JCO.19.00640","article-title":"MARS: mutation-adjusted risk score for advanced systemic mastocytosis","volume":"37","author":"Jawhar","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2024.08.034_bib64","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1111\/all.15675","article-title":"Optimal dose of adrenaline auto-injector for children and young people at risk of anaphylaxis: a phase IV randomized controlled crossover study","volume":"78","author":"Patel","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib65","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13223-021-00634-2","article-title":"CSACI position statement: transition recommendations on existing epinephrine autoinjectors","volume":"17","author":"Li","year":"2021","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib66","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.jaip.2023.04.037","article-title":"Refractory anaphylaxis: a new entity for severe anaphylaxis","volume":"11","author":"Pouessel","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib67","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib68","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199208063270603","article-title":"Fatal and near-fatal anaphylactic reactions to food in children and adolescents","volume":"327","author":"Sampson","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.08.034_bib69","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0140-6736(03)12827-9","article-title":"Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial","volume":"361","author":"Brown","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.08.034_bib70","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.anai.2019.02.018","article-title":"Imported fire ant hypersensitivity and mastocytosis: a case series of successful venom immunotherapy","volume":"122","author":"Nath","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM197807272990401","article-title":"A\u00a0controlled trial of immunotherapy in insect hypersensitivity","volume":"299","author":"Hunt","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.08.034_bib72","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0091-6749(92)90073-B","article-title":"Imported fire ant immunotherapy: effectiveness of whole body extracts","volume":"90","author":"Freeman","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0091-6749(97)70188-X","article-title":"Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients","volume":"100","author":"Fricker","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib74","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaci.2007.11.010","article-title":"Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis","volume":"121","author":"Gonz\u00e1lez de Olano","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib75","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jaip.2019.10.022","article-title":"One-day ultrarush desensitization for Hymenoptera venom anaphylaxis in patients with and without mast cell disorders with adjuvant omalizumab","volume":"8","author":"Giannetti","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib76","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jaip.2013.07.004","article-title":"Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome","volume":"1","author":"da Silva","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5414\/ALX02196E","article-title":"Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis","volume":"5","author":"G\u00fclsen","year":"2021","journal-title":"Allergol Select"},{"key":"10.1016\/j.jaip.2024.08.034_bib78","doi-asserted-by":"crossref","first-page":"318","DOI":"10.18176\/jiaci.0395","article-title":"Usefulness of omalizumab and sting challenge test in hymenoptera venom allergy and mastocytosis","volume":"29","author":"Gonz\u00e1lez-de-Olano","year":"2019","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib79","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaip.2017.11.025","article-title":"Anaphylactic reactions after discontinuation of hymenoptera venom immunotherapy: a clonal mast cell disorder should be suspected","volume":"6","author":"Bonadonna","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib80","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaip.2024.02.026","article-title":"Safety of sting challenge test in patients with clonal mast cell diseases","volume":"12","author":"Vega-Castro","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.034_bib81","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/s41591-021-01539-8","article-title":"Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial","volume":"27","author":"Gotlib","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2024.08.034_bib82","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41591-021-01538-9","article-title":"Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial","volume":"27","author":"DeAngelo","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2024.08.034_bib83","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1182\/bloodadvances.2022007539","article-title":"Efficacy and safety of avapritinib in previously treated patients with advanced systemic mastocytosis","volume":"6","author":"Reiter","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2024.08.034_bib84","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.08.034_bib85","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jaci.2020.03.044","article-title":"Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis","volume":"146","author":"Hartmann","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib86","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200339","article-title":"Avapritinib versus placebo in indolent systemic mastocytosis","volume":"2","author":"Gotlib","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jaip.2024.08.034_bib87","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jaci.2020.08.015","article-title":"Persistent, refractory, and biphasic anaphylaxis: a multidisciplinary Delphi study","volume":"146","author":"Dribin","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib88","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3389\/fimmu.2019.02482","article-title":"Refractory anaphylaxis: data from the european anaphylaxis registry","volume":"10","author":"Francuzik","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib89","doi-asserted-by":"crossref","first-page":"756","DOI":"10.15585\/mmwr.mm7227a6","article-title":"QuickStats: number of deaths from hornet, wasp, and bee stings\u2217 among males and females - National Vital Statistics System, United States, 2011-2021","volume":"72","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jaip.2024.08.034_bib90","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0091-6749(73)90044-4","article-title":"Studies of 400 Hymenoptera sting deaths in the United States","volume":"52","author":"Barnard","year":"1973","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib91","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0091-6749(89)90319-9","article-title":"Survey of fatal anaphylactic reactions to imported fire ant stings. Report of the Fire Ant Subcommittee of the American Academy of Allergy and Immunology","volume":"84","author":"Rhoades","year":"1989","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.034_bib92","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/all.13237","article-title":"Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: efficacy and safety observations","volume":"73","author":"Broesby-Olsen","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.034_bib93","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1159\/000504842","article-title":"Efficacy of omalizumab in mastocytosis: allusive indication obtained from a prospective, double-blind, multicenter study (XOLMA Study)","volume":"236","author":"Distler","year":"2020","journal-title":"Dermatology (Basel)"},{"key":"10.1016\/j.jaip.2024.08.034_bib94","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(23)01684-7","article-title":"Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials","volume":"403","author":"Maurer","year":"2024","journal-title":"Lancet"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824008535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824008535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:15:37Z","timestamp":1762607737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824008535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213219824008535"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.08.034","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mast Cell Disorders and Hymenoptera Venom-Triggered Anaphylaxis: Evaluation and Management","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}